Assignee
SOLIGENIX INC
US·9 granted patents·9 pending applications·4 citations·filing 2012–2024
Top patents by PatentIndex Score
18 records- 0189US11433129B2Compositions and methods of manufacturing trivalent filovirus vaccinesSOLIGENIX INC·Filed 2020·Granted Sep 6, 2022·3 cites·7 claims
- 0286US11771757B2Compositions and methods of manufacturing trivalent filovirus vaccinesSOLIGENIX INC·Filed 2022·Granted Oct 3, 2023·1 cites·8 claims
- 0370US2024189413A1Compositions and Methods of Manufacturing Trivalent Filovirus VaccinesSOLIGENIX INC·Filed 2023·Application pending·0 cites
- 0465US10526268B2Systems and methods for producing synthetic hypericinSOLIGENIX INC·Filed 2018·Granted Jan 7, 2020·0 cites·13 claims
- 0565US2020155571A1Topically Active Steroids for Use in Radiation and Chemotherapeutics InjurySOLIGENIX INC·Filed 2019·Application pending·0 cites
- 0658US2025195604A1Compositions and Methods of Treatment of Certain Vasculitis SyndromesSOLIGENIX INC·Filed 2024·Application pending·0 cites
- 0758US2025127761A1Telmisartan Nanosuspension for Therapy of Respiratory Infections and Methods of Making and Using SameSOLIGENIX INC·Filed 2023·Application pending·0 cites
- 0856US10053413B2Systems and methods for producing synthetic hypericinSOLIGENIX INC·Filed 2016·Granted Aug 21, 2018·0 cites·9 claims
- 0954US10253068B2Peptides and analogs for use in the treatment of oral mucositisSOLIGENIX INC·Filed 2017·Granted Apr 9, 2019·0 cites·7 claims
- 1053US9850279B2Peptides and analogs for use in the treatment of oral mucositisSOLIGENIX INC·Filed 2014·Granted Dec 26, 2017·0 cites·6 claims
- 1151US11311598B2Peptides and analogs for use in the treatment of oral mucositisSOLIGENIX INC·Filed 2019·Granted Apr 26, 2022·0 cites·9 claims
- 1250US2024009297A1Antibody/Adjuvant Compositions and Methods of Immune Response Generation against CoronavirusesSOLIGENIX INC·Filed 2021·Application pending·0 cites
- 1348US2017333448A1Topically Active Steroids For Use in Radiation and Chemotherapeutics InjurySOLIGENIX INC·Filed 2017·Application pending·0 cites
- 1446US2023024050A1Dermatological Compositions and Methods of Treatment against Cutaneous T-Cell LymphomaSOLIGENIX INC·Filed 2022·Application pending·0 cites
- 1545US2015148304A1Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation SyndromeSOLIGENIX INC·Filed 2014·Application pending·0 cites
- 1644US9763963B2Topically active steroids for use in interstitial pulmonary fibrosisSOLIGENIX INC·Filed 2015·Granted Sep 19, 2017·0 cites·9 claims
- 1744US2014328929A1Method of Preventing Acute Graft-Versus-Host Disease using Oral Beclomethasone DipropionateSOLIGENIX INC·Filed 2012·Application pending·0 cites
- 1841US10293041B2Multivalent stable vaccine composition and methods of making sameSOLIGENIX INC·Filed 2015·Granted May 21, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SOLIGENIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →